⌘K

Login Start Free

Home/Filings/4/0001144204-16-086169

4//SEC Filing

CASI Pharmaceuticals, Inc. 4

Accession 0001144204-16-086169

CIK 0000895051operating

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:49 PM ET

Size

5.4 KB

Accession

0001144204-16-086169

Insider Transaction Report

Form 4

Period: 2016-03-02

CASI Pharmaceuticals, Inc.CASI

Chief Executive Officer

Transactions

Award
Stock Options (Right to Buy)
2016-03-02+125,000→ 125,000 total
Exercise: $0.88Exp: 2026-03-02→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]The stock options vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.

Documents

1 file

4
v433405_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000895051

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 4:49 PM ET
Size: 5.4 KB

View on SEC.gov